Description
Nobivac® DHPPi
Lyophilisate and solvent for suspension for injection
Reg. No. G2377 (Act 36/1947)
Namibia Reg. No. V97/24.1/900 [NS2]
Only for use by or under the supervision of persons registered in terms of or authorised in terms of Section 23 (1) (c) of the Veterinary and Para-veterinary Professions Act, 1982 (Act no. 19 of 1982).
INDICATIONS
For the active immunisation of dogs against canine distemper, infectious canine hepatitis, canine parvovirus disease and canine parainfluenza virus infection.
COMPOSITION
Each 0,5 mℓ vial of the lyophilised substance contains live, attenuated strains of:
- canine distemper virus (CDV) not less than 104 TCID50,
- canine adenovirus type 2 (CAV2) not less than 104 TCID50,
- canine parvovirus (CPV) not less than 107 TCID50 and
- canine parainfluenza virus (CPI) not less than 105,5 TCID50.
Each vial contains a single dose for reconstitution.
